# Use of OCT Imaging in the Treatment of Right Coronary Artery Occlusion Causing NSTEMI as an Initial Complication of Essential Thrombocythaemia

**Authors:** Robert Michael, Jith Somaratne, Nicola Eaddy

PMC · DOI: 10.1155/cric/6647538 · Case Reports in Cardiology · 2026-02-25

## TL;DR

A 39-year-old woman with essential thrombocythaemia developed a heart attack, and OCT imaging helped guide treatment by identifying a blood clot.

## Contribution

Demonstrates OCT's utility in diagnosing thrombus in NSTEMI caused by ET, a rare presentation.

## Key findings

- OCT identified thrombus without atherosclerotic plaque in a patient with ET.
- OCT-guided stenting achieved optimal blood flow in a rare ET-related NSTEMI case.

## Abstract

Essential thrombocythaemia (ET) is a chronic myeloproliferative neoplasm characterised by clonal thrombocytosis and an overall increased risk of thrombotic events. Acute coronary syndrome as an initial presentation of ET is rare in the literature.

A 39 year old woman with established ET presented with non‐ST‐elevation myocardial infarction (NSTEMI). Coronary angiography revealed a hazy, eccentric mid‐right coronary artery lesion. Optical coherence tomography (OCT) demonstrated thrombus without atherosclerotic plaque. OCT‐guided direct stenting achieved optimal expansion with thrombolysis in myocardial infarction (TIMI) Grade III flow. She was discharged on dual antiplatelet therapy and referred to haematology for ET management. At three months, she remained asymptomatic on clinic follow‐up.

OCT provided diagnostic and procedural guidance in a rare thrombotic NSTEMI secondary to ET. This case highlights the role of intracoronary imaging in differentiating thrombosis from atherosclerotic plaque rupture.

## Linked entities

- **Diseases:** myeloproliferative neoplasm (MONDO:0020076)

## Full-text entities

- **Genes:** CALR (calreticulin) [NCBI Gene 811] {aka CALR1, CRT, HEL-S-99n, RO, SSA, cC1qR}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, MPL (MPL proto-oncogene, thrombopoietin receptor) [NCBI Gene 4352] {aka C-MPL, CD110, MPLV, THCYT2, THPOR, TPOR}
- **Diseases:** myocardial infarction (MESH:D009203), cytotoxic (MESH:D064420), Coronary Artery Occlusion (MESH:D054059), ET (MESH:D020329), ischaemic (MESH:D018917), thrombosis (MESH:D013927), hypertension (MESH:D006973), atherosclerotic (MESH:D050197), Coronary Events (MESH:D003323), depression (MESH:D003866), miscarriage (MESH:D000022), clonal thrombocytosis (MESH:D013922), peripheral oedema (MESH:D010523), coronary artery disease (MESH:D003324), motion abnormalities (MESH:D009041), myeloproliferative neoplasm (MESH:D009369), atherosclerotic plaque rupture (MESH:D012421), valvular abnormalities (MESH:D006349), cytotoxic drugs (MESH:D000092582), NSTEMI (MESH:D000072658), coronary disease (MESH:D003327), ACS (MESH:D054058), stenosis (MESH:D003251), megakaryocytic hyperplasia (MESH:D007947), myocardial ischaemia (MESH:D009202), chest pain (MESH:D002637)
- **Chemicals:** Onyx (-), ticagrelor (MESH:D000077486), anagrelide (MESH:C021139), hydroxyurea (MESH:D006918), enoxaparin (MESH:D017984), aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** JAK2, V617F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933134/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933134/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933134/full.md

---
Source: https://tomesphere.com/paper/PMC12933134